Subscribe To
Elbit systems: shot down but getting up
The aerospace and defense industry is recovering and the outlook is positive. Elbit Systems Ltd is Israel's biggest public high-tech arms and weapons ...
January 18, 2023, 11:04 pm
Discover (dfs) q4 earnings and revenues beat estimates
Discover (DFS) delivered earnings and revenue surprises of 5.31% and 2.28%, respectively, for the quarter ended December 2022. Do the numbers hold clu...
January 18, 2023, 6:49 pm
Indivior: healthy defensive in a difficult economy
Drug addiction is on the rise but so are treatments for it, like those provided by Indivior for opioid usage. With growing re...
January 18, 2023, 5:51 pm
United airlines (ual) tops q4 earnings, revenues rise y/y
United Airlines' (UAL) fourth-quarter 2022 revenues benefited from the recovery of air-travel demand an...
January 18, 2023, 5:19 pm
J.b. hunt (jbht) q4 earnings lag estimates, down y/y
J.B. Hunt (JBHT) fourth-quarter 2022 earnings decrease year over year, revenues increase....
January 18, 2023, 3:48 pm
Calfrac well services: a buying opportunity that won't last
Calfrac is the market leader in Canada and has a strong position in the U.S. The company has grown revenues ...
January 18, 2023, 3:33 pm
Meta: decades of growth ahead on fundamentals
Facebook revenues, although declining, will persist strongly for awhile. Instagram and WhatsApp are well-positioned to deliver growth over a long dura...
January 18, 2023, 3:11 pm
Sba communications: strong earnings growth despite churn concerns
SBA Communications Corporation has continued to show strong growth in revenues and earnings. The compan...
January 18, 2023, 12:52 pm
Prologis' (pld) ffo and revenues surpass estimates in q4
Prologis' (PLD) fourth-quarter 2022 results outshine estimates, benefiting from healthy leasing activity and solid rent growth. It provides 2023 outlo...
January 18, 2023, 12:03 pm
Schwab (schw) down as q4 earnings & revenues lag estimates
Rise in net interest income and absence of fee waivers support Schwab's (SCHW) Q4 earnings amid heightened equity market volatility that hurt trading ...
January 18, 2023, 12:03 pm
Hancock whitney (hwc) q4 earnings beat estimates, revenues rise
Higher revenues, increasing loan balances and higher rates support Hancock Whitney's (HWC) Q4 earnings. However, increasing expenses and provisions ar...
January 18, 2023, 11:19 am
Here's why you may consider adding wix to your portfolio
WIX's performance is benefiting from continued momentum seen in annualized recurring revenues from Crea...
January 18, 2023, 10:33 am
Cigna corporation is at a great entry price
Cigna Corporation is a massive health insurance company with over $190 billion in TTM revenues. With strong cash flow, the company is well set up to t...
January 18, 2023, 4:02 am
Fulton financial (fult) q4 earnings and revenues lag estimates
Fulton Financial (FULT) delivered earnings and revenue surprises of -4% and 0.29%, respectively, for the quarter ended December 2022. Do the numbers h...
January 17, 2023, 7:34 pm
Interactive brokers group, inc. (ibkr) q4 earnings and revenues surpass estimates
Interactive Brokers Group, Inc. (IBKR) delivered earnings and revenue surprises of 12.07% and 5.31%, respectively, for the quarter ended December 2022...
January 17, 2023, 6:49 pm
Epi: bet on indian growth
If you believe in continued downward pressures on oil prices like me, exposure to oil-import nations such as India via ETFs such as WisdomTree India E...
January 17, 2023, 5:55 pm
Elevance health offers great value
Elevance Health Inc. is a massive company operating in the insurance space, with over 47 million members. Elevance Health re...
January 17, 2023, 4:26 pm
Discover financial stock to beat the earnings consensus in q4?
We expect Discover Financial to beat the consensus estimates of earnings, but revenues will slightly mi...
January 17, 2023, 1:00 pm
Will cost headwinds dampen danaher's (dhr) q4 earnings?
High raw material costs and supply-chain disruptions are likely to have hurt Danaher's (DHR) Q4 earnings. However, the top line is likely to have bene...
January 17, 2023, 12:48 pm
Corcept (cort) rides on robust korlym sales, high reliance a woe
Corcept's (CORT) Cushing's syndrome drug Korlym is witnessing higher sales and a strong uptake since approval. However, sole dependence on Korlym for ...
January 17, 2023, 12:48 pm